GELSOMINO, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 2.770
AS - Asia 2.419
EU - Europa 1.535
SA - Sud America 677
AF - Africa 191
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 7.605
Nazione #
US - Stati Uniti d'America 2.642
SG - Singapore 965
BR - Brasile 511
CN - Cina 479
VN - Vietnam 408
UA - Ucraina 323
IT - Italia 315
DE - Germania 268
AT - Austria 187
SE - Svezia 128
BD - Bangladesh 88
FR - Francia 78
HK - Hong Kong 78
SN - Senegal 78
IN - India 67
CA - Canada 59
AR - Argentina 54
FI - Finlandia 54
KR - Corea 53
MX - Messico 45
TR - Turchia 44
GB - Regno Unito 43
IQ - Iraq 38
ZA - Sudafrica 37
ID - Indonesia 29
PK - Pakistan 29
RU - Federazione Russa 28
EC - Ecuador 27
MA - Marocco 25
VE - Venezuela 21
NL - Olanda 18
CL - Cile 17
CO - Colombia 17
SA - Arabia Saudita 16
PL - Polonia 15
MY - Malesia 13
UZ - Uzbekistan 13
BE - Belgio 12
ES - Italia 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 10
JP - Giappone 10
PY - Paraguay 10
DZ - Algeria 9
UY - Uruguay 9
CZ - Repubblica Ceca 8
EG - Egitto 8
JO - Giordania 8
IL - Israele 7
PE - Perù 7
AL - Albania 6
AU - Australia 6
OM - Oman 6
PH - Filippine 6
DO - Repubblica Dominicana 5
EU - Europa 5
IR - Iran 5
KE - Kenya 5
BA - Bosnia-Erzegovina 4
BO - Bolivia 4
CH - Svizzera 4
LT - Lituania 4
NP - Nepal 4
SY - Repubblica araba siriana 4
AM - Armenia 3
AO - Angola 3
BG - Bulgaria 3
GT - Guatemala 3
HN - Honduras 3
IE - Irlanda 3
KG - Kirghizistan 3
KZ - Kazakistan 3
LB - Libano 3
LK - Sri Lanka 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
LY - Libia 2
MD - Moldavia 2
NI - Nicaragua 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
TH - Thailandia 2
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
Totale 7.586
Città #
Singapore 352
Chandler 345
San Jose 290
Dallas 238
Ashburn 213
Ho Chi Minh City 147
Jacksonville 138
Vienna 134
San Mateo 130
Beijing 128
Boardman 115
New York 114
Hanoi 81
Hong Kong 78
Dakar 77
Munich 61
Dearborn 55
Seoul 53
Shanghai 53
Lauterbourg 48
Los Angeles 47
Roxbury 44
São Paulo 44
Lawrence 43
Rende 38
Council Bluffs 37
Da Nang 30
Florence 30
Hefei 30
Helsinki 30
Bremen 26
Brooklyn 26
Cosenza 26
Des Moines 24
Ottawa 24
The Dalles 24
Inglewood 23
Izmir 23
Santa Clara 23
Ann Arbor 22
Turku 21
Haiphong 20
Orem 20
Johannesburg 19
Wilmington 19
Pune 17
Rio de Janeiro 17
Seattle 17
Columbus 16
Redwood City 16
Rome 16
Guangzhou 15
Curitiba 13
Ogden 13
Toronto 13
Biên Hòa 12
Porto Alegre 12
Tashkent 12
Baghdad 11
Brussels 11
Chennai 11
Frankfurt am Main 11
Hải Dương 11
Milan 11
Warsaw 11
Amsterdam 10
Jakarta 10
Mexico City 10
Quito 10
Tianjin 10
Baku 9
Bari 9
Dhaka 9
Hillsboro 9
Kuala Lumpur 9
Lahore 9
Montreal 9
Tokyo 9
Mumbai 8
Phoenix 8
Santiago 8
Belo Horizonte 7
Brasília 7
Catanzaro 7
Chicago 7
Düsseldorf 7
Erbil 7
Fortaleza 7
Guarulhos 7
Guayaquil 7
Nanjing 7
Ninh Bình 7
San Francisco 7
Thái Bình 7
Boston 6
Campinas 6
Grafing 6
Montevideo 6
Riyadh 6
Zhengzhou 6
Totale 4.102
Nome #
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 225
Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts 200
Leptin and Notch Signaling Cooperate in Sustaining Glioblastoma Multiforme Progression 196
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Cytokine Signaling Network 180
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 176
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 176
Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a 175
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: An Additional Mechanism in Cell-to-Cell Communication 175
The emerging role of adiponectin in female malignancies 175
Evidence for enhanced exosome production in aromatase inhibitor-resistant breast cancer cells 173
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 172
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 172
Leptin Receptor as a Potential Target to Inhibit Human Testicular Seminoma Growth 167
Uncoupling effects of estrogen receptor α on LKB1/AMPK interaction upon adiponectin exposure in breast cancer 166
Knockdown of Leptin Receptor Affects Macrophage Phenotype in the Tumor Microenvironment Inhibiting Breast Cancer Growth and Progression 162
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 160
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 159
Interfering Role of ERα on Adiponectin Action in Breast Cancer 159
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 158
Farnesoid X Receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through down-regulation of HER2 expression 155
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 155
Novel insights into adiponectin action in breast cancer: Evidence of its mechanistic effects mediated by ERα expression 152
Modulating Tumor-Associated Macrophage polarization by synthetic and natural PPARγ ligands as a potential target in breast cancer 150
Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 146
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer 144
Oldenlandia Diffusa extracts exert antiproliferative and apoptotic effects on human breast cancer cells through ERα/Sp1-mediated p53 activation 139
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 137
The Role of PPARγ Ligands in Breast Cancer: from Basic Research to Clinical Studies 133
Development of a Leptin Antagonist Peptide: Implications for Breast Cancer 129
Adiponectin Influences the Behavior of Stem Cells in Hormone-Resistant Breast Cancer 127
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression. 127
May tumor microenvironment cooperate with a mutant ERalpha to promote breast cancer progression? 126
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells 124
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth. 123
Targeting thyroid hormone receptor beta in triple-negative breast cancer 122
ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling 121
Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages 120
Obesity, leptin and breast cancer: Epidemiological evidence and proposed mechanisms 118
Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines 118
Natural and synthetic PPARγ ligands in tumor microenvironment: a new potential strategy against breast cancer 110
Obesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives 109
Hormonal modulation of ESR1 mutant metastasis 108
Leptin: A Heavyweight Player in Obesity-Related Cancers 104
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts 103
ERα/LKB1 complex upregulates E-cadherin expression and stimulates breast cancer growth and progression upon adiponectin exposure 103
Uncoupling effects of ERalpha on LKB1/AMPK signaling induced by adiponectin in breast cancer cells 98
The biology of exosomes in breast cancer progression: Dissemination, immune evasion and metastatic colonization 97
Tumor microenviroment cooperate with a mutant ERalpha to promote breast cancer progression? 90
May tumor microenvironment cooperate with a mutant ERα to promote breast cancer progression? 89
The Emerging Role of Extracellular Vesicles in Endocrine Resistant Breast Cancer 89
Proteomic Profiling of Extracellular Vesicles Released by Leptin-Treated Breast Cancer Cells: A Potential Role in Cancer Metabolism 87
CEBP-β and PLK1 as Potential Mediators of the Breast Cancer/Obesity Crosstalk: In Vitro and In Silico Analyses 85
miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer 81
Unraveling Obesity and Multiple Myeloma: Insights from Epidemiology and Molecular Mechanisms 78
Complex Interplay Between Obesity and BRCA1/2-Associated Breast Cancer: An Overview 73
TXNIP in cancer: Unlocking biological insights and tackling clinical challenges 64
null 51
Extracellular vesicles in multiple myeloma-bone marrow niche crosstalk: from cellular dialogue to clinical perspectives 42
Adipocyte‑derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross‑talk between cancer cells and the tumor microenvironment 25
Skin Carotenoid Score as a Potential Early Biomarker of Metabolic Syndrome Risk in Adolescents 22
Adipocyte/Tumor cell crosstalk via IGF-1/TXNIP axis promotes malignancy and endocrine resistance in breast cancer 22
Interplay between Leptin and Stearoyl-CoA Desaturase 1 in Estrogen Receptor–Positive Breast Cancer Cells 20
Totale 7.742
Categoria #
all - tutte 38.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.707


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202123 0 0 0 0 0 0 0 0 0 0 0 23
2021/2022631 6 107 6 79 57 10 1 145 9 3 70 138
2022/2023879 90 123 43 111 115 78 18 115 79 14 56 37
2023/2024659 74 39 54 31 42 161 15 63 45 28 29 78
2024/20251.227 82 120 23 74 72 63 69 82 193 98 111 240
2025/20263.576 361 165 422 232 684 307 374 260 315 227 206 23
Totale 7.742